Side effects of treatments are the fifth cause of death in hospitals, according to a report cited b

"The best vaccine against common infectious diseases is an adequate diet." (World Health iservice Organization) "Multiple sclerosis, a disease that eventually leaves its victims totally paralyzed, is one of the affections of thousands of people suffering in the western world. Yet, this disease is completely unknown Africans, Asians and South Americans have not "received" excellent western medicine. Amyotrophic lateral sclerosis, a terrible disease of the neuromuscular system is also unknown to everyone in the mentioned areas. The same situation is and with myopathy and muscular dystrophy seen only in the west. Epilepsy iservice that is increasing in developed countries is very rare in other countries. Anxiety neuroses, compulsive neurosis and generally suffering severe mental illness million iservice patients in the western world are almost unknown in these groups do not have "benefited" modern medicine and vaccination. "(Professor George Vithoulkas speech, 1994 Swedish Parliament).
Side effects of treatments are the fifth cause of death in hospitals, according to a report cited by the European press. Adverse drug reactions are monitored by specialized international agencies, but are kept secret. Reports of adverse drug reactions, performed consistently doctors were not made public until now. A team of journalists iservice from Denmark, the Netherlands and Belgium found that in relationships, worrying figures are circulating: adverse effects of drugs are the fifth cause of death recorded in hospitals, show publication "EUobserver." Also during this week, "Los Angeles Times" published a report according to which, in the US, the number of deaths caused by adverse drug reactions has tripled in the first quarter of 2008 compared to the previous year. The debate comes when the European Regulatory Medicines Agency (EMEA) has decided to withdraw from the market antiobesity treatment considered safe until a few days ago. Interpretable results disclosures European journalists have sparked heated discussions on patients' rights to be informed about the risks they run when they take certain treatments. "Without a doubt, the reports should be made public. After all, it is about the medicines we take, "said Margrethe iservice Nielsen, a researcher at the Cochrane Institute in Copenhagen, which recognizes the usefulness of the reports to the public. Experts, however, believe that the results could be misinterpreted by the public, so should be working documents only authorized agencies. "Many undesirable events that occur during drug administration are not necessarily adverse reactions", says John Fulga, specialist in pharmacology. Companies threatens court Pharmaceutical companies fear that reports iservice can be used to their disadvantage. Reacting iservice to a report published in 2007, the pharmaceutical company Roche has threatened to sue the Danish State if the disclosures made by the authorities of this country will affect the commercial interests iservice of the company. "A iservice competitor can use these reports as a basis to guide patients and doctors. With these reports, iservice you can create guidelines that threaten Roche's position in the market and thus can be made firm Roche global damage, "said the company's legal representatives. In turn, Americans are pointing fingers iservice towards iservice drugs for smoking cessation - containing varenicline - but also to heparin, an anticoagulant used to prevent thrombosis. Balance benefits, risks assumed rule, any drug, no matter how "harmless" is expected iservice to have adverse effects, ranging from minor to the most severe type of respiratory disorders or suicidal tendencies. For example, aspirin can cause bleeding strong, especially in people with ulcers. "Purpose of the studies done in hospitals and private clinics indicates whether a drug is effective and what are the risks acceptable. If the risk-benefit ratio is in favor of the benefits, the drug can be given, "said Calin Ciubotaru GP. Efficient, but uncertain paradox do that when launching a product, authorities know only efficacy in clinical trials, not his safety. "Previous studies of launching the drug are rigorously made, but they can not detect all adverse iservice reactions. They may be found only after the drug into long-term therapy, as the number of people using the drug is higher. Compensated controversial Organ